HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anne-Laure Vallier Selected Research

Circulating Tumor DNA

11/2019POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anne-Laure Vallier Research Topics

Disease

12Breast Neoplasms (Breast Cancer)
01/2020 - 02/2014
4Cardiotoxicity
01/2020 - 12/2016
2Neutropenia
01/2016 - 12/2015
1Triple Negative Breast Neoplasms
04/2024
1Hyperglycemia
11/2019
1Neoplasms (Cancer)
11/2019
1Mucositis
11/2019
1Diarrhea
11/2019
1Residual Neoplasm
01/2017
1Cardiovascular Diseases (Cardiovascular Disease)
12/2016
1Genetic Risk Score
01/2016
1Obesity
12/2015

Drug/Important Bio-Agent (IBA)

4Trastuzumab (Herceptin)FDA Link
01/2020 - 12/2016
3AnthracyclinesIBA
04/2024 - 02/2014
3Paclitaxel (Taxol)FDA LinkGeneric
04/2024 - 02/2014
2taxaneIBA
01/2016 - 05/2014
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2015 - 02/2014
2Epirubicin (Ellence)FDA LinkGeneric
06/2015 - 02/2014
1Carboplatin (JM8)FDA LinkGeneric
04/2024
1olaparibIBA
04/2024
1human ERBB2 proteinIBA
01/2020
12- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA
11/2019
1Estrogen ReceptorsIBA
11/2019
1TamoxifenFDA LinkGeneric
11/2019
1Hormones (Hormone)IBA
11/2019
1DNA (Deoxyribonucleic Acid)IBA
11/2019
1Circulating Tumor DNAIBA
11/2019
1Protein Isoforms (Isoforms)IBA
11/2019
1Genetic Markers (Genetic Marker)IBA
01/2016
1Investigational DrugsIBA
09/2015
1Fluorouracil (Carac)FDA LinkGeneric
06/2015
1Bevacizumab (Avastin)FDA Link
06/2015
1Docetaxel (Taxotere)FDA Link
06/2015
1GemcitabineFDA Link
02/2014
1Taxoids (Taxanes)IBA
02/2014

Therapy/Procedure

9Drug Therapy (Chemotherapy)
04/2024 - 02/2014
4Neoadjuvant Therapy
01/2017 - 02/2014
2Adjuvant Chemotherapy
01/2016 - 12/2015
1Therapeutics
11/2019
1Treatment Delay
12/2016